Alpha-1 Antitrypsin Deficiency Treatment Market to Set Phenomenal Growth from 2017 to 2025

Mylan Inc. (US): Received FDA approval in November 2018 for YUPELRI, a long-acting muscarinic antagonist nebulized bronchodilator.

Leading Market Players

1. Kamada Pharmaceuticals (Israel)
2. CSL Behring LLC (US)
3. Grifols, S.A. (Spain)
4. Takeda Pharmaceutical Company Limited (Japan)
5. GlaxoSmithKline plc (UK)
6. Boehringer Ingelheim GmbH (Germany)
7. AstraZeneca (UK)
8. Vectura Group plc (UK)
9. Pfizer Inc. (US)
10. Mylan Inc. (US)

Free sample copy is here @ https://www.marketresearchfuture.com/sample_request/8319

Market Forecast

Registering a CAGR of 10.50%, the global alpha-1 antitrypsin deficiency treatment market is expected to grow from USD 1,464.1 million in 2018 to USD 2,914.7 million by 2025.

As of July 2019, 3.4 million people are affected by alpha-1 antitrypsin deficiency worldwide. The disorder is found to affect populations in all the regions of the world.

Segmentation

By Drugs:

1. Alpha-1 Proteinase Inhibitor: The segment is expected to hold the largest market share as it is the only treatment for AATD, which protects the patient from more lung damage.
2. Bronchodilators: These are used for the treatment of respiratory disorders associated with AATD.
3. Steroids: These are used specifically for the treatment of chronic obstructive pulmonary disease, which affects the patient along with AATD.
4. Others: Other treatment options include antibiotics for infections and jaundice associated with AATD and oxygen therapy.

By Route of Administration:

1. Oral: The segment is expected to hold the largest market share.
2. Intravenous: The segment is expected to grow at the fastest CAGR.
3. Inhalation: This route of administration is used specifically for the administration of corticosteroids for treating breathing disorders.
4. Others: Subcutaneous and intramuscular routes of administration.

Table Of Content

1. REPORT PROLOGUE
2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

1. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

1. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

Continued….

Access the complete report @ https://www.marketresearchfuture.com/press-release/alpha-1-antitrypsin-deficiency-treatment

Key Questions Answered in This Report: endometrial cancer market

• What will the market size and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?

Browse other healthcare-related reports

Oral Thin Film Drugs Market – Global Forecast 2023

by Product (Fast Dissolving Buccal Film, Sublingual), by Disease Indication (Opioid Dependence, Nausea & Vomiting, Schizophrenia, Migraine), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Drug Stores), and Region

Needle-Free Injection Market

• Global Forecast 2023

By Product (Fillable) Technology (Jet-Based) Usability (Reusable), Type of Medication (Liquid-Based), Site of Delivery (Intra dermal), Application (Vaccination) End Users (Hospitals)

About Market Research Future:

MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Media Contact

Company Name: Market Research Future

Contact Person: Abhishek Sawant

Email: sales@marketresearchfuture.com

Phone: +1 646 845 9312

Address: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar

City: Pune

State: Maharashtra

Country: India

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Ma